What changed in September 2024 On September 20, 2024, the FDA announced that five of the 19 peptides were being removed from Category 2: AOD-9604, CJC-1295, Ipamorelin Acetate, Thymosin Alpha-1, and Selank Acetate
More serious but rare gastrointestinal complications have been reported, including pancreatitis (though causality remains debated), gallbladder disease, and ileus in susceptible individuals
There is limited data on the safety of glutathione during pregnancy, and it should only be used when the benefits justify the potential risks
The ability to reliably push below 0.5 ng/mL using PRM (MS/MS), combined with robust data handling in Chromeleon CDS, directly addresses real-world plasma matrix challenges